Of note, decreased lymphocyte subsets and increased cytokines (IL-6, IL-8, IL-10 and IFN-γ) may aid the early identification of patients at risk of severe and critical COVID-19 and provide more definitive and timely approaches for treatment. This evidence concerns the gene IL6 and COVID-19.